Patients with complex medical historiesrecent cardiac events, severe kidney disease, diabetic gastroparesis, or multiple comorbiditiesmay benefit from in-person evaluation before initiating GLP-1
doi: 10.1016/0031-9384(76)90109-8 113 ChenXGabittoMPengYRybaNJPZukerCS
Overall, the findings from the current literature are conflicting and inconclusive, although they raise some important questions about whether certain diet-based factors, including diets with a high UPF exposure, may contribute to and influence neurodevelopmental outcomes across both healthy development and in the case of ASD
doi:10.3389/fendo.2025.1621892 Nagae K, Uchi H, Morino-Koga S, Tanaka Y, Oda M, Furue M
NADPH oxidases: from molecular mechanisms to current inhibitors
PMCID: PMC9624240 DOI: 10.1161/CIRCULATIONAHA.122.061732 Packer M (2023): SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism